Back

The effect of ACE-I/ARBs and beta blockers on the development of cardiotoxicity in patients with breast cancer

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardio-oncology 1 Cardio-Oncology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Goyal Umadat

Mayo Clinic, Jacksonville (United States of America)

5 More presentations in this session

Presentation thumbnail
Prevalence of RV dysfunction in patients under cardiotoxic chemoterapy: a preliminary analysis
Doctor S. Maltes (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Valvular changes following anthracycline therapy: is it time to look beyond ejection fraction?
Doctor M. Laufer-Perl (Tel Aviv, IL)
Abstract Slides
Presentation thumbnail
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis - report from an international registry
Doctor P. Guedeney (Paris, FR)
Abstract Slides
Presentation thumbnail
Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: a study of 20.6 million records from the USA
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Cardio-Oncology: a medical specialty in constant growth and evolution. the 10-year experience of the first cardio-oncology service in the United Kingdom
Doctor M. Andres (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Cardio-oncology 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources